456 related articles for article (PubMed ID: 17160008)
1. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin.
Hohmann AG; Farthing JN; Zvonok AM; Makriyannis A
J Pharmacol Exp Ther; 2004 Feb; 308(2):446-53. PubMed ID: 14610224
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Makriyannis A; Hohmann AG
Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.
Rahn EJ; Zvonok AM; Thakur GA; Khanolkar AD; Makriyannis A; Hohmann AG
J Pharmacol Exp Ther; 2008 Nov; 327(2):584-91. PubMed ID: 18664590
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice.
Curto-Reyes V; Boto T; Hidalgo A; Menéndez L; Baamonde A
Eur J Pharmacol; 2011 Oct; 668(1-2):184-9. PubMed ID: 21771590
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation.
Potenzieri C; Brink TS; Pacharinsak C; Simone DA
J Neurophysiol; 2008 Nov; 100(5):2794-806. PubMed ID: 18784270
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.
Quartilho A; Mata HP; Ibrahim MM; Vanderah TW; Porreca F; Makriyannis A; Malan TP
Anesthesiology; 2003 Oct; 99(4):955-60. PubMed ID: 14508331
[TBL] [Abstract][Full Text] [Related]
8. 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
De Vry J; Denzer D; Reissmueller E; Eijckenboom M; Heil M; Meier H; Mauler F
J Pharmacol Exp Ther; 2004 Aug; 310(2):620-32. PubMed ID: 15140913
[TBL] [Abstract][Full Text] [Related]
9. Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.
Costa B; Giagnoni G; Franke C; Trovato AE; Colleoni M
Br J Pharmacol; 2004 Sep; 143(2):247-50. PubMed ID: 15313881
[TBL] [Abstract][Full Text] [Related]
10. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
11. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation.
Nackley AG; Zvonok AM; Makriyannis A; Hohmann AG
J Neurophysiol; 2004 Dec; 92(6):3562-74. PubMed ID: 15317842
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
[TBL] [Abstract][Full Text] [Related]
13. Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.
Curto-Reyes V; Llames S; Hidalgo A; Menéndez L; Baamonde A
Br J Pharmacol; 2010 Jun; 160(3):561-73. PubMed ID: 20233215
[TBL] [Abstract][Full Text] [Related]
14. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat.
Conti S; Costa B; Colleoni M; Parolaro D; Giagnoni G
Br J Pharmacol; 2002 Jan; 135(1):181-7. PubMed ID: 11786493
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation.
Rahn EJ; Zvonok AM; Makriyannis A; Hohmann AG
AAPS J; 2010 Jun; 12(2):147-57. PubMed ID: 20127295
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid CB1 receptor inhibition of mechanically evoked responses of spinal neurones in control rats, but not in rats with hindpaw inflammation.
Kelly S; Chapman V
Eur J Pharmacol; 2003 Aug; 474(2-3):209-16. PubMed ID: 12921864
[TBL] [Abstract][Full Text] [Related]
17. Endogenous cannabinoids induce fever through the activation of CB1 receptors.
Fraga D; Zanoni CI; Rae GA; Parada CA; Souza GE
Br J Pharmacol; 2009 Aug; 157(8):1494-501. PubMed ID: 19681872
[TBL] [Abstract][Full Text] [Related]
18. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
Naidu PS; Kinsey SG; Guo TL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2010 Jul; 334(1):182-90. PubMed ID: 20375198
[TBL] [Abstract][Full Text] [Related]
19. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
20. Effects of Se-phenyl thiazolidine-4-carboselenoate on mechanical and thermal hyperalgesia in brachial plexus avulsion in mice: mediation by cannabinoid CB1 and CB2 receptors.
Del Fabbro L; Borges Filho C; Cattelan Souza L; Savegnago L; Alves D; Henrique Schneider P; de Salles HD; Jesse CR
Brain Res; 2012 Sep; 1475():31-6. PubMed ID: 22902772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
